CL2003002748A1 - COMPOUNDS DERIVED FROM 1,2,4-TRIAMINOBENCEN; PHARMACEUTICAL COMPOSITION; AND ITS USE IN THE PREVENTION, TREATMENT AND / OR INHIBITION OF A CENTRAL NERVOUS SYSTEM DISORDER, SUCH AS CONVULSIONS, EPILEPSY, STATUS EPILEPTICUS, NEUROPATIC PAIN, AL - Google Patents
COMPOUNDS DERIVED FROM 1,2,4-TRIAMINOBENCEN; PHARMACEUTICAL COMPOSITION; AND ITS USE IN THE PREVENTION, TREATMENT AND / OR INHIBITION OF A CENTRAL NERVOUS SYSTEM DISORDER, SUCH AS CONVULSIONS, EPILEPSY, STATUS EPILEPTICUS, NEUROPATIC PAIN, ALInfo
- Publication number
- CL2003002748A1 CL2003002748A1 CL200302748A CL2003002748A CL2003002748A1 CL 2003002748 A1 CL2003002748 A1 CL 2003002748A1 CL 200302748 A CL200302748 A CL 200302748A CL 2003002748 A CL2003002748 A CL 2003002748A CL 2003002748 A1 CL2003002748 A1 CL 2003002748A1
- Authority
- CL
- Chile
- Prior art keywords
- triaminobencen
- convulsions
- epilepsy
- inhibition
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200202012 | 2002-12-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2003002748A1 true CL2003002748A1 (en) | 2005-04-08 |
Family
ID=35295526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200302748A CL2003002748A1 (en) | 2002-12-27 | 2003-12-24 | COMPOUNDS DERIVED FROM 1,2,4-TRIAMINOBENCEN; PHARMACEUTICAL COMPOSITION; AND ITS USE IN THE PREVENTION, TREATMENT AND / OR INHIBITION OF A CENTRAL NERVOUS SYSTEM DISORDER, SUCH AS CONVULSIONS, EPILEPSY, STATUS EPILEPTICUS, NEUROPATIC PAIN, AL |
Country Status (17)
| Country | Link |
|---|---|
| KR (1) | KR20050089862A (en) |
| CN (1) | CN100448867C (en) |
| AR (1) | AR042656A1 (en) |
| BR (1) | BR0317748A (en) |
| CL (1) | CL2003002748A1 (en) |
| EA (1) | EA008589B1 (en) |
| HK (1) | HK1088317A1 (en) |
| IS (1) | IS2649B (en) |
| MY (1) | MY139844A (en) |
| NO (1) | NO20053612L (en) |
| PE (1) | PE20041015A1 (en) |
| PL (1) | PL377221A1 (en) |
| SI (1) | SI1578740T1 (en) |
| TW (1) | TWI325414B (en) |
| UA (1) | UA79666C2 (en) |
| UY (1) | UY28151A1 (en) |
| ZA (1) | ZA200504565B (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4200259A1 (en) * | 1992-01-08 | 1993-07-15 | Asta Medica Ag | NEW 1,2,4-TRIAMINOBENZOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
| DE19539861A1 (en) * | 1995-10-26 | 1997-04-30 | Asta Medica Ag | Use of 4-amino-4- (4-fluorobenzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases |
| GB9915414D0 (en) * | 1999-07-01 | 1999-09-01 | Glaxo Group Ltd | Medical use |
| US6117900A (en) * | 1999-09-27 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of retigabine for the treatment of neuropathic pain |
| US6589986B2 (en) * | 2000-12-20 | 2003-07-08 | Wyeth | Methods of treating anxiety disorders |
-
2003
- 2003-12-18 UA UAA200507206A patent/UA79666C2/en unknown
- 2003-12-18 EA EA200501053A patent/EA008589B1/en not_active IP Right Cessation
- 2003-12-18 BR BR0317748-3A patent/BR0317748A/en not_active IP Right Cessation
- 2003-12-18 SI SI200330827T patent/SI1578740T1/en unknown
- 2003-12-18 PL PL377221A patent/PL377221A1/en unknown
- 2003-12-18 CN CNB2003801076953A patent/CN100448867C/en not_active Expired - Fee Related
- 2003-12-18 KR KR1020057012183A patent/KR20050089862A/en not_active Application Discontinuation
- 2003-12-18 TW TW092135930A patent/TWI325414B/en not_active IP Right Cessation
- 2003-12-22 AR ARP030104782A patent/AR042656A1/en unknown
- 2003-12-24 CL CL200302748A patent/CL2003002748A1/en unknown
- 2003-12-24 UY UY28151A patent/UY28151A1/en not_active Application Discontinuation
- 2003-12-26 MY MYPI20035008A patent/MY139844A/en unknown
-
2004
- 2004-01-05 PE PE2004000037A patent/PE20041015A1/en not_active Application Discontinuation
-
2005
- 2005-05-23 IS IS7856A patent/IS2649B/en unknown
- 2005-06-03 ZA ZA200504565A patent/ZA200504565B/en unknown
- 2005-07-25 NO NO20053612A patent/NO20053612L/en not_active Application Discontinuation
-
2006
- 2006-08-04 HK HK06108672.2A patent/HK1088317A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20053612D0 (en) | 2005-07-25 |
| CN100448867C (en) | 2009-01-07 |
| KR20050089862A (en) | 2005-09-08 |
| ZA200504565B (en) | 2006-08-30 |
| EA200501053A1 (en) | 2005-12-29 |
| UA79666C2 (en) | 2007-07-10 |
| CN1732162A (en) | 2006-02-08 |
| TWI325414B (en) | 2010-06-01 |
| BR0317748A (en) | 2005-11-22 |
| HK1088317A1 (en) | 2006-11-03 |
| EA008589B1 (en) | 2007-06-29 |
| MY139844A (en) | 2009-11-30 |
| IS7856A (en) | 2005-05-23 |
| PE20041015A1 (en) | 2005-01-08 |
| TW200413280A (en) | 2004-08-01 |
| IS2649B (en) | 2010-08-15 |
| SI1578740T1 (en) | 2007-08-31 |
| NO20053612L (en) | 2005-09-23 |
| PL377221A1 (en) | 2006-01-23 |
| UY28151A1 (en) | 2004-07-30 |
| AR042656A1 (en) | 2005-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200500221T2 (en) | Bicyclic Amino Acids as Pharmaceutical Substances | |
| IL176581A0 (en) | Immunomodulatory compounds for the treatment of central nervous system disorders | |
| CL2007003155A1 (en) | COMPOUNDS DERIVED FROM 3,7-DIAZABICICLO [3.3.0] OCTANO OR 3,7-DIAZABICICLO [3.3.1] NONANO, NEURONAL NICOTINIC RECEIVER MODULATORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CNS DISORDERS. | |
| EP1786515A4 (en) | Treatment of the autonomic nervous system | |
| IL172479A0 (en) | Peptides enhancing ceh activity or inhibiting acat activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis | |
| CL2007001882A1 (en) | COMPOUNDS DERIVED FROM IMIDAZOPIRIMIDINE; PROCESS TO PREPARE THE COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE PREVENTION AND / OR TREATMENT OF COGNITIVE DISORDERS. | |
| WO2007002884A3 (en) | 4-fluoro-piperidine t-type calcium channel antagonists | |
| CL2007001881A1 (en) | COMPOUNDS DERIVED FROM IMIDAZOPIRIMIDINE; PROCESS TO PREPARE THE COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE PREVENTION AND / OR TREATMENT OF COGNITIVE DISORDERS. | |
| WO2007002361A3 (en) | 3-fluoro-piperidine t-type calcium channel antagonists | |
| IL148052A0 (en) | Use of gaba antagonists for treatment of spastic disorders, convulsions, and epilepsy | |
| WO2002066500A3 (en) | ANTAGONISTS FPR Α4β7-INTEGRIN | |
| HK1060516A1 (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
| DK1411917T3 (en) | Carbamate compounds for use in the prevention or treatment of movement disorders | |
| CL2004001365A1 (en) | COMPOUNDS DERIVED FROM 3-FLUOROPIPERIDINE; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE OF THE COMPOUND TO TREAT OR PREVENT PARKINSON'S PAIN OR DISEASE. | |
| IL170710A0 (en) | Selective cytokine inhibitory drugs for treating disorders of the central nervous system | |
| HUP0303261A3 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| ZA200307475B (en) | Carbamate compounds for use in the treatment of pain. | |
| CL2004001421A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND DERIVED FROM 1,4-DIPIPERIDIN-4-IL-PIPERAZINA; AND ITS USE FOR THE PREVENTION AND / OR TREATMENT OF PAIN. | |
| ZA200509169B (en) | Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor | |
| CL2003002748A1 (en) | COMPOUNDS DERIVED FROM 1,2,4-TRIAMINOBENCEN; PHARMACEUTICAL COMPOSITION; AND ITS USE IN THE PREVENTION, TREATMENT AND / OR INHIBITION OF A CENTRAL NERVOUS SYSTEM DISORDER, SUCH AS CONVULSIONS, EPILEPSY, STATUS EPILEPTICUS, NEUROPATIC PAIN, AL | |
| EP1697536A4 (en) | Novel oligonucleotides and treating cardiac disorders by using the same | |
| MXPA04000008A (en) | Carbamates of 2-heterocyclic-1,2-ethanediols. | |
| AU2003202255A8 (en) | Compositions for treatment of central nervous system neoplasms, and methods of making and using the same | |
| MX9804577A (en) | Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders. | |
| ES2173334T3 (en) | COMPOSITIONS CONTAINING BISMUTO, FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS. |